Nogueira, L.R.; Maderuelo, A.; Alva Bianchi, M.; Tolosa, P.; Lema, L.; Montes, J.; Zumárraga, T.; Madariaga, A.; Manso, L.; Aragón Sánchez, S.;
et al. Implementation of HER2DX Scores into Treatment Decisions in Early-Stage HER2-Positive Breast Cancer. Int. J. Mol. Sci. 2026, 27, 5293.
https://doi.org/10.3390/ijms27125293
AMA Style
Nogueira LR, Maderuelo A, Alva Bianchi M, Tolosa P, Lema L, Montes J, Zumárraga T, Madariaga A, Manso L, Aragón Sánchez S,
et al. Implementation of HER2DX Scores into Treatment Decisions in Early-Stage HER2-Positive Breast Cancer. International Journal of Molecular Sciences. 2026; 27(12):5293.
https://doi.org/10.3390/ijms27125293
Chicago/Turabian Style
Nogueira, Lola R., Ana Maderuelo, Manuel Alva Bianchi, Pablo Tolosa, Laura Lema, Juan Montes, Teresa Zumárraga, Ainhoa Madariaga, Luis Manso, SofÃa Aragón Sánchez,
and et al. 2026. "Implementation of HER2DX Scores into Treatment Decisions in Early-Stage HER2-Positive Breast Cancer" International Journal of Molecular Sciences 27, no. 12: 5293.
https://doi.org/10.3390/ijms27125293
APA Style
Nogueira, L. R., Maderuelo, A., Alva Bianchi, M., Tolosa, P., Lema, L., Montes, J., Zumárraga, T., Madariaga, A., Manso, L., Aragón Sánchez, S., Sanz, C., Ruano, Y., Ciruelos Gil, E., & Sánchez-Bayona, R.
(2026). Implementation of HER2DX Scores into Treatment Decisions in Early-Stage HER2-Positive Breast Cancer. International Journal of Molecular Sciences, 27(12), 5293.
https://doi.org/10.3390/ijms27125293
